[1]冯松林 余皓 吴欣择 李朝阳 施森.MicroRNA在腹主动脉瘤发生和发展中的调控机制[J].心血管病学进展,2020,(11):1168-1172.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
 Abdominal Aortic Aneurysm.Regulatory Mechanism of MicroRNA in Occurrence and Development of[J].Advances in Cardiovascular Diseases,2020,(11):1168-1172.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
点击复制

MicroRNA在腹主动脉瘤发生和发展中的调控机制()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年11期
页码:
1168-1172
栏目:
综述
出版日期:
2020-11-25

文章信息/Info

Title:
Regulatory Mechanism of MicroRNA in Occurrence and Development of
文章编号:
202004119
作者:
冯松林 余皓 吴欣择 李朝阳 施森
李朝阳 施森(西南医科大学附属医院血管外科,四川 泸州 646000)
Author(s):
Abdominal Aortic Aneurysm
FENG SonglinYU HaoWU XinzeLI ChaoyangSHI Sen (Department of Vascular Surgery,The Affiliated Hospital of Southwest Medical University,Luzhou 646000,Sichuan,China)
关键词:
腹主动脉瘤MicroRNA调控机制治疗方式
Keywords:
Abdominal aortic aneurysmMicroRNARegulatory mechanismTreatment
DOI:
10.16806/j.cnki.issn.1004-3934.2020.11.000
摘要:
腹主动脉瘤是指腹主动脉局部永久性扩张,其发病机制复杂。已有大量研究证实microRNA可通过细胞外基质降解的调控、血管平滑肌细胞凋亡、血管炎症反应和氧化应激等病理过程影响腹主动脉瘤的发生和发展。MicroRNA有望成为腹主动脉瘤生物学标志物及潜在治疗靶点,靶向干预microRNA表达有望成为腹主动脉瘤新的治疗方式。现主要在病理调控机制方面综述与腹主动脉瘤相关microRNA。
Abstract:
Abdominal aortic aneurysm(AAA)refers to the local permanent expansion of the abdominal aorta, and its pathogenesis is complicated. A large number of studies have confirmed that microRNA can affect the occurrence and development of AAA by the regulation of extracellular matrix (ECM) degradation, vascular smooth muscle cell apoptosis, vascular inflammation reaction , and oxidative stress. MicroRNA is expected to become a biological marker and potential therapeutic target for AAA. Through targeted intervention of microRNA expression, it is expected to become a new treatment method for AAA.This review focuses on the role of microRNA in the pathogenesis of abdominal aortic aneurysm.

参考文献/References:

[1]Aber A,Tong TS,Chilcott J,et al. Sex differences in national rates of repair of emergency abdominal aortic aneurysm[J]. Br J Surg,2019,106(1):82-89.

[2]Lederle FA. The strange relationship between diabetes and abdominal aortic aneurysm[J]. Eur J Vasc Endovasc Surg,2012,43(3):254-256.

[3]Lu TX,Rothenberg ME. MicroRNA[J].J Allergy Clin Immunol,2018,141(4):1202-1207.

[4]Maegdefessel L,Azuma J,Tsao PS. MicroRNA-29b regulation of abdominal aortic aneurysm development[J]. Trends Cardiovasc Med,2014,24(1):1-6.

[5]Licholai S,Szczeklik W,Sanak M. miR-29c-3p is an effective biomarker of abdominal aortic aneurysm in patients undergoing elective surgery[J].Microrna,2016,5(2):124-131.

[6]Sun Y,Zhong L,He X,et al. LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA[J]. J Mol Cell Cardiol,2019,131:66-81.

[7]Spear R,Boytard L,Blervaque R,et al. Let-7f:a new potential circulating biomarker identified by miRNA profiling of cells isolated from human abdominal aortic aneurysm [J]. Int J Mol Sci,2019,20(21):5499.

[8]Maegdefessel L,Azuma J,Toh R,et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion[J]. Sci Transl Med,2012,4(122):122ra22.

[9]He X,Wang S,Li M,et al. Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis[J]. Theranostics,2019,9(19):5558-5576.

[10]Li X,Wei Y,Wang Z. MicroRNA-21 and hypertension[J]. Hypertens Res,2018,41(9):649-661.

[11]Leeper NJ,Raiesdana A,Kojima Y,et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation[J]. Arterioscler Thromb Vasc Biol,2013,33 (1):e1-e10.

[12]Gan S,Pan Y,Mao J. miR-30a-GNG2 and miR-15b-ACSS2 interaction pairs may be potentially crucial for development of abdominal aortic aneurysm by influencing inflammation[J]. DNA Cell Biol,2019,38(12):1540-1556.

[13]Zampetaki A,Attia R,Mayr U,et al. Role of miR-195 in aortic aneurysmal disease[J]. Circ Res,2014,115(10):857-866.

[14]Ma X,Yao H,Yang Y,et al. miR-195 suppresses abdominal aortic aneurysm through the TNF-α/NF-κB and VEGF/PI3K/AKT pathway[J].Int J Mol Med,2018,41(4):2350-2358.

[15]Liang B,Che J,Zhao H,et al. MiR-195 promotes abdominal aortic aneurysm media remodeling by targeting Smad3[J]. Cardiovasc Ther,2017,35(6).DOI:10.1111/1755-5922.12286.

[16]Peng J,He X,Zhang L,et al. MicroRNA-26a protects vascular smooth muscle cells against H2O2-induced injury through activation of the PTEN/AKT/mTOR pathway[J]. Int J Mol Med,2018,42(3):1367-1378.

[17]Huang W,Huang C,Ding H,et al. Involvement of miR-145 in the development of aortic dissection via inducing proliferation, migration, and apoptosis of vascular smooth muscle cells[J]. J Clin Lab Anal,2020,34(1):e23028.

[18]Li T,Liu C,Liu L,et al. Regulatory mechanism of microRNA-145 in the pathogenesis of acute aortic dissection[J]. Yonsei Med J,2019,60(4):352-359.

[19]Wu J,Wang J,Li X,et al. MicroRNA-145 mediates the formation of angiotensin Ⅱ-induced murine abdominal aortic aneurysm[J]. Heart Lung Circ,2017,26(6):619-626.

[20]Biros E,Moran CS,Wang Y,et al. MicroRNA profiling in patients with abdominal aortic aneurysms:the significance of miR-155[J]. Clin Sci,2014,126(11):795-803.

[21]Zhang Z,Liang K,Zou G,et al. Inhibition of miR-155 attenuates abdominal aortic aneurysm in mice by regulating macrophage-mediated inflammation[J]. Biosci Rep,2018,38 (3):BSR20171432.

[22]Zhao L,Ouyang Y,Bai Y,et al. miR-155-5p inhibits the viability of vascular smooth muscle cell via targeting FOS and ZIC3 to promote aneurysm formation[J]. Eur J Pharmacol, 2019,853:145-152.

[23]Jiao T,Yao Y,Zhang B,et al. Role of microRNA-103a targeting ADAM10 in abdominal aortic aneurysm[J]. Biomed Res Int,2017,2017:9645874.

[24]Kim CW,Kumar S,Son DJ,et al. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin Ⅱ-infused mice[J]. Arterioscler Thromb Vasc Biol,2014,34(7):1412-1421.

[25]Chan CY,Chan YC,Cheuk BL,et al. Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm[J]. J Vasc Surg,2017,65(2):509-520.

[26]Shen G,Sun Q,Yao Y,et al. Role of ADAM9 and miR-126 in the development of abdominal aortic aneurysm[J]. Atherosclerosis,2020,297:47-54.

[27]Venkatesh P,Phillippi J,Chukkapalli S,et al. Aneurysm-specific miR-221 and miR-146a participates in human thoracic and abdominal aortic aneurysms[J]. Int J Mol Sci,2017,18 (4):875.

[28]Wang X,Searle AK,Hohmann JD,et al. Dual-targeted theranostic delivery of miRs arrests abdominal aortic aneurysm development[J]. Mol Ther,2018,26(4):1056-1065.

相似文献/References:

[1]李思瑶 钟江华.MicroRNA与心房颤动关系的研究进展[J].心血管病学进展,2020,(1):34.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.010]
 LI SiyaoZHONG Jianghua.The Relationship Between MicroRNA and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(11):34.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.010]
[2]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
 XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(11):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[3]王盛姣 关秀茹.MicroRNA与细胞焦亡在动脉粥样硬化中的作用研究[J].心血管病学进展,2020,(5):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
 WANG Shengjiao,GUAN Xiuru.MicroRNA and Pyroptosis in Atherosclerosis[J].Advances in Cardiovascular Diseases,2020,(11):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
[4]谭海鹏 高金峰 李琦玉 王樵梓 张宁 陈婧 黄浙勇.MicroRNA促进心肌细胞再生机制的研究进展[J].心血管病学进展,2020,(7):698.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.007]
 TAN Haipeng,GAO Jinfeng,LI Qiyu,et al.Mechanism of MicroRNA Promoting Cardiomyocyte Regeneration[J].Advances in Cardiovascular Diseases,2020,(11):698.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.007]
[5]陈秋宏 王春彬 吴奇.肺动脉高压相关生物标志物的研究新进展[J].心血管病学进展,2021,(11):986.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
 CHEN Qiuhong,WANG Chunbin,WU Qi.Pulmonary Hypertension-Related Biomarkers[J].Advances in Cardiovascular Diseases,2021,(11):986.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[6]蔡一帆 董倩 俞坤武 曾秋棠.炎症细胞参与腹主动脉瘤的研究进展[J].心血管病学进展,2022,(7):630.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
 CAI Yifan,Dong Qian,YU Kunwu,et al.Pathogenesis of Inflammatory Cell in Abdominal Aortic Aneurysm[J].Advances in Cardiovascular Diseases,2022,(11):630.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[7]周强 曹勖 王睿.血管平滑肌细胞线粒体与腹主动脉瘤发生发展的研究进展[J].心血管病学进展,2024,(5):442.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.014]
 ZHOU Qiang,CAO Xu,WANG Rui.Vascular Smooth Muscle Cell Mitochondria and Abdominal Aortic Aneurysm Formation and Development[J].Advances in Cardiovascular Diseases,2024,(11):442.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.014]

更新日期/Last Update: 2021-02-04